The EIT Health Summit will less than 3 weeks and we are excited to meet the key industry voices to discuss sustainable healthcare transformation that has an impact and delivers better care for all citizens.
More than ever, the COVID-19 crisis has highlighted the need for innovative thinking and new ways of working in light of the challenges presented by the COVID-19 pandemic, as well as the future sustainability and resilience of healthcare services.
With this in mind, this year’s flagship event will explore how healthcare systems can incorporate and reform new care delivery and financial approaches, to learn from the impact of COVID and ensure that healthcare systems are sustainable, resilient and prepared for future health threats.
We have created an exciting programme for this year’s Summit which incorporates opinions and views of healthcare thought leaders from around 30 different countries. Ensuring that the content presents the most cutting-edge themes and thinking is the Advisory Group, which includes experts from the European Commission, Karolinska Institutet, European Patients’ Forum, OECD, BioMed Alliance and many more.
The two-day event will explore how we can build a framework for transformation with world-class speakers taking to the stage to share their expertise, inspiring talks, interactive Q&As, and workshops.
Here are some of our personal highlights:
The untapped power of data in public health (24 May, 14:45-15:45) with Nick Schneider (Head of Division 511 on new technologies and data use working at the German Federal Ministry of Health)
- The pandemic has proven unequivocally that public health is intrinsically linked with overall social wellbeing and prosperity. It has also demonstrated the vital role data plays in helping us to prepare, respond and recover from public health threats. That being said, the global approach to data-driven pandemic action was not optimal and there is much to be learned. Join us for this session which will cover how we can use data – and indeed big data – for surveillance purposes to protect society from communicable and non-communicable diseases, how some of the key COVID-19 tracing tools were utilised during the pandemic and how their effectiveness can be improved in the future, and how we can strengthen the resilience of European health systems overall through the utilisation of precise and real-time data.
Winning together: a recipe for successful corporate and start-up collaboration (24 May, 16:00-17:00) with Matthias Zach (Programme Lead of Startup Creasphere working at Roche)
- This session will offer both perspectives of a corporate and a start-up who succeeded and walk you through do’s and don’t’s of setting up the right environment for open innovation, where exchange of value is in both directions. You will hear about common pitfalls and learn how to navigate them from those who stay ahead of the curve.
The rise of telehealth (25 May, 09:00-10:00) with Thorsten Lambertus (Head of neurotechlabs Germany working at Biogen)
- Healthcare is moving toward hybrid care models that combine digital and on-site services. However, telecare is more than adding digital tools to traditional, face-to-face clinician visits. Transformations in healthcare consist of different components, which address patient pathways, better patient and carers engagement and more efficient use of data and connected devices. The transition requires a change in culture, new/advanced skills, advanced platforms for continuous data management, a new healthcare architecture with updated reimbursement models, and a prevention-oriented approach. Are we ready to realise the full potential of telemedicine?
Life sciences in transition (25 May, 10:30-11:30) with Emily Jordan (Co-founder and COO at Ancora.ai.)
- New advancements in science –mRNA, CRISPR genome editing, molecular biology, bioengineering, artificial intelligence algorithms and big data –raise hope for improved prevention, diagnosis, treatment and patient outcomes. COVID-19 has opened new doors for us in life sciences –putting both new and existing (but underused) technologies to the test and gaining vital experience. Not only that, but change happened within – decentralised clinical trials, data-driven drug discovery, and a faster path to market for new products.
Leading from the front: a discussion with our selected leading start-ups (II) (25 May, 11:45-12:45) with Matthias Roos (Pharma Sector Lead at Climedo)
- The pandemic has taught us many lessons, not least the need for preventive, predictive and digitised health care.Join us to hear from a compelling selection of EIT Health supported start-ups and projects implementing solutions such as hybrid care, data-driven approaches to research and development, and preventative measures to keep people healthy and disease-free. Each will present for 7 minutes on their solution and the audience will have the opportunity to address questions and have a conversation with them.
Follow this link to get to know the whole agenda.
The EIT Health Summit 2022 will be available to attend either in person in Stockholm or online with selected sessions and networking available via an events platform which will allow attendees to tune in virtually.